Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Linh-Chi Ho’s research focuses on the potential of prenylated stilbenoids, specifically arachidin-1 derived from peanuts, as an adjuvant therapy for triple-negative breast cancer. Her work investigates how arachidin-1 may enhance the efficacy of conventional chemotherapy agents like paclitaxel in treating this aggressive form of cancer. Ho has published four papers on this topic, with recent work exploring arachidin-1's role in inducing apoptosis and augmenting paclitaxel's anticancer effects in triple-negative breast cancer cells. Her research network includes collaborators from Arkansas State University, including Fabricio Medina-Bolívar, Jianfeng Xu, and Tra Le, as well as Alexx Weaver from the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications.
Metrics
- h-index: 2
- Publications: 4
- Citations: 34
Selected Publications
-
Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells (2023)
-
Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer (2022)
-
Arachidin-1, a Prenylated Stilbenoid from Peanut, Induces Apoptosis in Triple-Negative Breast Cancer Cells (2022)
Collaboration Network
Top Collaborators
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Induces Apoptosis in Triple-Negative Breast Cancer Cells
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
- Abstract 2653: Arachidin-1 Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Induces Apoptosis in Triple-Negative Breast Cancer Cells
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Abstract 2653: Arachidin-1 Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
- Abstract 2653: Arachidin-1 Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Induces Apoptosis in Triple-Negative Breast Cancer Cells
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Induces Apoptosis in Triple-Negative Breast Cancer Cells
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
Similar Researchers
Based on overlapping research topics